APO Research

APO RESEARCH · REPORT

Quetiapine Fumarate Tablets

Selected research

Market Structure

Global Quetiapine Fumarate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Quetiapine Fumarate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Quetiapine Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Quetiapine Fumarate Tablets include Teva Pharmaceuticals, Sun Pharma, Sandoz, Lupin Limited, Hunan Dongting Pharmaceutical, Hikma, Dr. Reddy's Laboratories, AstraZeneca and Alkem Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Quetiapine Fumarate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Quetiapine Fumarate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Quetiapine Fumarate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quetiapine Fumarate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Quetiapine Fumarate Tablets Segment by Company

Teva Pharmaceuticals

Sun Pharma

Sandoz

Lupin Limited

Hunan Dongting Pharmaceutical

Hikma

Dr. Reddy's Laboratories

AstraZeneca

Alkem Laboratories

Quetiapine Fumarate Tablets Segment by Type

0.2g

0.3g

Others

Quetiapine Fumarate Tablets Segment by Application

Hospital

Clinic

Others

Quetiapine Fumarate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quetiapine Fumarate Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Quetiapine Fumarate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Quetiapine Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Quetiapine Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Quetiapine Fumarate Tablets Industry Trends Table 2. Quetiapine Fumarate Tablets Industry Drivers Table 3. Quetiapine Fumarate Tablets Industry Opportunities and Challenges Table 4. Quetiapine Fumarate Tablets Industry Restraints Table 5. Global Quetiapine Fumarate Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Quetiapine Fumarate Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Quetiapine Fumarate Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Quetiapine Fumarate Tablets Sales Market Share by Manufacturers Table 9. Global Quetiapine Fumarate Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Quetiapine Fumarate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Quetiapine Fumarate Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Quetiapine Fumarate Tablets Manufacturers, Product Type & Application Table 13. Global Quetiapine Fumarate Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Quetiapine Fumarate Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.2g Table 17. Major Manufacturers of 0.3g Table 18. Major Manufacturers of Others Table 19. Global Quetiapine Fumarate Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Quetiapine Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 21. Global Quetiapine Fumarate Tablets Sales by Type (2027-2032) & (K Units) Table 22. Global Quetiapine Fumarate Tablets Sales Market Share by Type (2021-2026) Table 23. Global Quetiapine Fumarate Tablets Sales Market Share by Type (2027-2032) Table 24. Global Quetiapine Fumarate Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Quetiapine Fumarate Tablets Revenue by Type (2021-2026) & (K Units) Table 26. Global Quetiapine Fumarate Tablets Revenue by Type (2027-2032) & (K Units) Table 27. Global Quetiapine Fumarate Tablets Revenue Market Share by Type (2021-2026) Table 28. Global Quetiapine Fumarate Tablets Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Others Table 32. Global Quetiapine Fumarate Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Quetiapine Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 34. Global Quetiapine Fumarate Tablets Sales by Application (2027-2032) & (K Units) Table 35. Global Quetiapine Fumarate Tablets Sales Market Share by Application (2021-2026) Table 36. Global Quetiapine Fumarate Tablets Sales Market Share by Application (2027-2032) Table 37. Global Quetiapine Fumarate Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Quetiapine Fumarate Tablets Revenue by Application (2021-2026) & (K Units) Table 39. Global Quetiapine Fumarate Tablets Revenue by Application (2027-2032) & (K Units) Table 40. Global Quetiapine Fumarate Tablets Revenue Market Share by Application (2021-2026) Table 41. Global Quetiapine Fumarate Tablets Revenue Market Share by Application (2027-2032) Table 42. Global Quetiapine Fumarate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Quetiapine Fumarate Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Quetiapine Fumarate Tablets Sales Market Share by Region (2021-2026) Table 45. Global Quetiapine Fumarate Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Quetiapine Fumarate Tablets Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Quetiapine Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 49. North America Quetiapine Fumarate Tablets Sales by Country (2027-2032) & (K Units) Table 50. Europe Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Quetiapine Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 52. Europe Quetiapine Fumarate Tablets Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Quetiapine Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Quetiapine Fumarate Tablets Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Quetiapine Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Quetiapine Fumarate Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Quetiapine Fumarate Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Quetiapine Fumarate Tablets Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Quetiapine Fumarate Tablets Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Quetiapine Fumarate Tablets Revenue Market Share by Region (2021-2026) Table 63. Global Quetiapine Fumarate Tablets Revenue Market Share by Region (2027-2032) Table 64. Teva Pharmaceuticals Company Information Table 65. Teva Pharmaceuticals Business Overview Table 66. Teva Pharmaceuticals Quetiapine Fumarate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Pharmaceuticals Quetiapine Fumarate Tablets Product Portfolio Table 68. Teva Pharmaceuticals Recent Development Table 69. Sun Pharma Company Information Table 70. Sun Pharma Business Overview Table 71. Sun Pharma Quetiapine Fumarate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sun Pharma Quetiapine Fumarate Tablets Product Portfolio Table 73. Sun Pharma Recent Development Table 74. Sandoz Company Information Table 75. Sandoz Business Overview Table 76. Sandoz Quetiapine Fumarate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sandoz Quetiapine Fumarate Tablets Product Portfolio Table 78. Sandoz Recent Development Table 79. Lupin Limited Company Information Table 80. Lupin Limited Business Overview Table 81. Lupin Limited Quetiapine Fumarate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Lupin Limited Quetiapine Fumarate Tablets Product Portfolio Table 83. Lupin Limited Recent Development Table 84. Hunan Dongting Pharmaceutical Company Information Table 85. Hunan Dongting Pharmaceutical Business Overview Table 86. Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Product Portfolio Table 88. Hunan Dongting Pharmaceutical Recent Development Table 89. Hikma Company Information Table 90. Hikma Business Overview Table 91. Hikma Quetiapine Fumarate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Hikma Quetiapine Fumarate Tablets Product Portfolio Table 93. Hikma Recent Development Table 94. Dr. Reddy's Laboratories Company Information Table 95. Dr. Reddy's Laboratories Business Overview Table 96. Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Product Portfolio Table 98. Dr. Reddy's Laboratories Recent Development Table 99. AstraZeneca Company Information Table 100. AstraZeneca Business Overview Table 101. AstraZeneca Quetiapine Fumarate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. AstraZeneca Quetiapine Fumarate Tablets Product Portfolio Table 103. AstraZeneca Recent Development Table 104. Alkem Laboratories Company Information Table 105. Alkem Laboratories Business Overview Table 106. Alkem Laboratories Quetiapine Fumarate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Alkem Laboratories Quetiapine Fumarate Tablets Product Portfolio Table 108. Alkem Laboratories Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Quetiapine Fumarate Tablets Distributors List Table 112. Quetiapine Fumarate Tablets Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Quetiapine Fumarate Tablets Product Image Figure 2. Global Quetiapine Fumarate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quetiapine Fumarate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Quetiapine Fumarate Tablets Sales (2021-2032) & (K Units) Figure 5. Global Quetiapine Fumarate Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Quetiapine Fumarate Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.2g Image Figure 9. 0.3g Image Figure 10. Others Image Figure 11. Global Quetiapine Fumarate Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Quetiapine Fumarate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Quetiapine Fumarate Tablets Sales Market Share by Type (2021-2032) Figure 14. Global Quetiapine Fumarate Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Quetiapine Fumarate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Quetiapine Fumarate Tablets Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Quetiapine Fumarate Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Quetiapine Fumarate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Quetiapine Fumarate Tablets Sales Market Share by Application (2021-2032) Figure 23. Global Quetiapine Fumarate Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Quetiapine Fumarate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Quetiapine Fumarate Tablets Revenue Market Share by Application (2021-2032) Figure 26. North America Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Quetiapine Fumarate Tablets Sales Market Share by Country (2021-2032) Figure 28. U.S. Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Quetiapine Fumarate Tablets Sales Market Share by Country (2021-2032) Figure 33. Germany Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Quetiapine Fumarate Tablets Sales Market Share by Country (2021-2032) Figure 40. China Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Quetiapine Fumarate Tablets Sales Market Share by Country (2021-2032) Figure 48. Brazil Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Quetiapine Fumarate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Quetiapine Fumarate Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Quetiapine Fumarate Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Quetiapine Fumarate Tablets Revenue (2021-2032) & (US$ Million) Figure 59. North America Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Quetiapine Fumarate Tablets Revenue (2021-2032) & (US$ Million) Figure 61. Europe Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Quetiapine Fumarate Tablets Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Quetiapine Fumarate Tablets Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Quetiapine Fumarate Tablets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Quetiapine Fumarate Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 0.2g
  • 0.3g
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva Pharmaceuticals
  • Sun Pharma
  • Sandoz
  • Lupin Limited
  • Hunan Dongting Pharmaceutical
  • Hikma
  • Dr. Reddy's Laboratories
  • AstraZeneca
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Quetiapine Fumarate Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Quetiapine Fumarate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Quetiapine Fumarate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Quetiapine Fumarate Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Quetiapine Fumarate Tablets Market Dynamics
  1. 2.1 Quetiapine Fumarate Tablets Industry Trends
  2. 2.2 Quetiapine Fumarate Tablets Industry Drivers
  3. 2.3 Quetiapine Fumarate Tablets Industry Opportunities and Challenges
  4. 2.4 Quetiapine Fumarate Tablets Industry Restraints
3 Quetiapine Fumarate Tablets Market by Manufacturers
  1. 3.1 Global Quetiapine Fumarate Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Quetiapine Fumarate Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Quetiapine Fumarate Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Quetiapine Fumarate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Quetiapine Fumarate Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Quetiapine Fumarate Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Quetiapine Fumarate Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Quetiapine Fumarate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Quetiapine Fumarate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Quetiapine Fumarate Tablets Tier 1, Tier 2, and Tier 3
4 Quetiapine Fumarate Tablets Market by Type
  1. 4.1 Quetiapine Fumarate Tablets Type Introduction
  2. 4.1.1 0.2g
  3. 4.1.2 0.3g
  4. 4.1.3 Others
  5. 4.2 Global Quetiapine Fumarate Tablets Sales by Type
  6. 4.2.1 Global Quetiapine Fumarate Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Quetiapine Fumarate Tablets Sales by Type (2021-2032)
  8. 4.2.3 Global Quetiapine Fumarate Tablets Sales Market Share by Type (2021-2032)
  9. 4.3 Global Quetiapine Fumarate Tablets Revenue by Type
  10. 4.3.1 Global Quetiapine Fumarate Tablets Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Quetiapine Fumarate Tablets Revenue by Type (2021-2032)
  12. 4.3.3 Global Quetiapine Fumarate Tablets Revenue Market Share by Type (2021-2032)
5 Quetiapine Fumarate Tablets Market by Application
  1. 5.1 Quetiapine Fumarate Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Quetiapine Fumarate Tablets Sales by Application
  6. 5.2.1 Global Quetiapine Fumarate Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Quetiapine Fumarate Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Quetiapine Fumarate Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Quetiapine Fumarate Tablets Revenue by Application
  10. 5.3.1 Global Quetiapine Fumarate Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Quetiapine Fumarate Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Quetiapine Fumarate Tablets Revenue Market Share by Application (2021-2032)
6 Global Quetiapine Fumarate Tablets Sales by Region
  1. 6.1 Global Quetiapine Fumarate Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Quetiapine Fumarate Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Quetiapine Fumarate Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Quetiapine Fumarate Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Quetiapine Fumarate Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Quetiapine Fumarate Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Quetiapine Fumarate Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Quetiapine Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Quetiapine Fumarate Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Quetiapine Fumarate Tablets Revenue by Region
  1. 7.1 Global Quetiapine Fumarate Tablets Revenue by Region
  2. 7.1.1 Global Quetiapine Fumarate Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Quetiapine Fumarate Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Quetiapine Fumarate Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Quetiapine Fumarate Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Quetiapine Fumarate Tablets Revenue (2021-2032)
  8. 7.2.2 North America Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Quetiapine Fumarate Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Quetiapine Fumarate Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Quetiapine Fumarate Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Quetiapine Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Quetiapine Fumarate Tablets Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Sun Pharma
  8. 8.2.1 Sun Pharma Company Information
  9. 8.2.2 Sun Pharma Business Overview
  10. 8.2.3 Sun Pharma Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharma Quetiapine Fumarate Tablets Product Portfolio
  12. 8.2.5 Sun Pharma Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Quetiapine Fumarate Tablets Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Lupin Limited
  20. 8.4.1 Lupin Limited Company Information
  21. 8.4.2 Lupin Limited Business Overview
  22. 8.4.3 Lupin Limited Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lupin Limited Quetiapine Fumarate Tablets Product Portfolio
  24. 8.4.5 Lupin Limited Recent Developments
  25. 8.5 Hunan Dongting Pharmaceutical
  26. 8.5.1 Hunan Dongting Pharmaceutical Company Information
  27. 8.5.2 Hunan Dongting Pharmaceutical Business Overview
  28. 8.5.3 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hunan Dongting Pharmaceutical Quetiapine Fumarate Tablets Product Portfolio
  30. 8.5.5 Hunan Dongting Pharmaceutical Recent Developments
  31. 8.6 Hikma
  32. 8.6.1 Hikma Company Information
  33. 8.6.2 Hikma Business Overview
  34. 8.6.3 Hikma Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hikma Quetiapine Fumarate Tablets Product Portfolio
  36. 8.6.5 Hikma Recent Developments
  37. 8.7 Dr. Reddy's Laboratories
  38. 8.7.1 Dr. Reddy's Laboratories Company Information
  39. 8.7.2 Dr. Reddy's Laboratories Business Overview
  40. 8.7.3 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dr. Reddy's Laboratories Quetiapine Fumarate Tablets Product Portfolio
  42. 8.7.5 Dr. Reddy's Laboratories Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Quetiapine Fumarate Tablets Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Alkem Laboratories
  50. 8.9.1 Alkem Laboratories Company Information
  51. 8.9.2 Alkem Laboratories Business Overview
  52. 8.9.3 Alkem Laboratories Quetiapine Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alkem Laboratories Quetiapine Fumarate Tablets Product Portfolio
  54. 8.9.5 Alkem Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Quetiapine Fumarate Tablets Value Chain Analysis
  2. 9.1.1 Quetiapine Fumarate Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Quetiapine Fumarate Tablets Production Mode & Process
  6. 9.2 Quetiapine Fumarate Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Quetiapine Fumarate Tablets Distributors
  9. 9.2.3 Quetiapine Fumarate Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research